rizatriptan Oral solution 5 mg, 10 mg

Established in 1989, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 12 countries and regions, including Algeria, Bahrain, Iraq, Jordan, Kuwait, Oman, Qatar, Saudi Arabia, Sudan, Switzerland, and the UAE . With a dedicated team of over 2,000 employees, it operates GMP-certified facilities producing a diverse range of products, including solids, liquids, cytotoxic drugs, and sterile injectables . As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​